Published in Stroke on January 27, 2005
Stroke caregiver outcomes from the Telephone Assessment and Skill-Building Kit (TASK). Top Stroke Rehabil (2009) 1.12
Quality of life of post-stroke patients and their caregivers. J Med Life (2010) 0.94
Are there gender, racial or relationship differences in caregiver task difficulty, depressive symptoms and life changes among stroke family caregivers? Brain Inj (2014) 0.85
Task difficulty and life changes among stroke family caregivers: relationship to depressive symptoms. Arch Phys Med Rehabil (2014) 0.84
Long-term health-related quality of life of stroke survivors and their spousal caregivers. J Neurosci Nurs (2013) 0.83
A problem-solving early intervention for stroke caregivers: one year follow-up. Rehabil Nurs (2012) 0.81
The relationship between parental depressive symptoms, family type, and adolescent functioning. PLoS One (2013) 0.81
A Depression Recognition and Treatment package for families living with Stroke (DepReT-Stroke): study protocol for a randomised controlled trial. Trials (2011) 0.81
Key neuropsychiatric symptoms in common dementias: prevalence and implications for caregivers, clinicians, and health systems. Res Gerontol Nurs (2013) 0.81
Patterns of relationships between background characteristics, coping, and stroke caregiver outcomes. Top Stroke Rehabil (2010) 0.80
Factors associated with stroke survivor behaviors as identified by family caregivers. Rehabil Nurs (2013) 0.80
Caregiver stress in stroke survivor: data from a tertiary care hospital -a cross sectional survey. BMC Psychol (2014) 0.80
The COMPlaints After Stroke (COMPAS) study: protocol for a Dutch cohort study on poststroke subjective cognitive complaints. BMJ Open (2013) 0.79
Differential aspects of stroke and congestive heart failure in quality of life reduction: a case series with three comparison groups. Health Qual Life Outcomes (2011) 0.79
Telephone Assessment and Skill-Building Kit for Stroke Caregivers: A Randomized Controlled Clinical Trial. Stroke (2015) 0.78
Lifestyle as a health risk for family caregivers with least life satisfaction, in home-based post-stroke caring. Healthc Policy (2013) 0.76
Clinical Implications of Family-Centered Care in Stroke Rehabilitation. Rehabil Nurs (2015) 0.75
Occupational therapy after stroke. BMJ (2007) 0.75
Association of quality of life of carers with quality of life and functional independence of stroke survivors. J Family Med Prim Care (2016) 0.75
Qualitative focus group study investigating experiences of accessing and engaging with social care services: perspectives of carers from diverse ethnic groups caring for stroke survivors. BMJ Open (2016) 0.75
The role of meaning in life: mediating the effects of perceived knowledge of stroke on depression and life satisfaction among stroke survivors. Clin Rehabil (2017) 0.75
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med (2008) 28.42
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 12.92
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet (2003) 6.63
Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry (2007) 6.20
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke (2004) 4.39
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98
Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry (2004) 3.92
Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke (2009) 3.39
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Prognosis and safety of anticoagulation in intracranial artery dissections in adults. Stroke (2007) 2.95
Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology (2012) 2.91
Thrombolysis of basilar artery occlusion: impact of baseline ischemia and time. Ann Neurol (2013) 2.77
Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry (2006) 2.53
Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch Gen Psychiatry (2007) 2.45
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry (2004) 2.24
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord (2007) 2.16
The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res (2006) 2.16
Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry (2010) 2.09
Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry (2002) 2.08
Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A (2007) 2.04
Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One (2010) 2.03
Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry (2004) 2.01
Depressive symptoms in adolescence as predictors of early adulthood depressive disorders and maladjustment. Am J Psychiatry (2002) 1.93
Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry (2007) 1.93
Fertility of patients with schizophrenia, their siblings, and the general population: a cohort study from 1950 to 1959 in Finland. Am J Psychiatry (2003) 1.92
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke (2008) 1.91
Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet (2003) 1.87
Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry (2003) 1.83
Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke (2010) 1.80
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Effectiveness of primary and comprehensive stroke centers: PERFECT stroke: a nationwide observational study from Finland. Stroke (2010) 1.73
The relationship between job-related burnout and depressive disorders--results from the Finnish Health 2000 Study. J Affect Disord (2005) 1.67
The main components of stroke unit care: results of a European expert survey. Cerebrovasc Dis (2007) 1.64
Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke (2009) 1.63
Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry (2007) 1.61
The association between burnout and physical illness in the general population--results from the Finnish Health 2000 Study. J Psychosom Res (2006) 1.61
The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr Res (2006) 1.57
Age at onset and cognitive functioning in schizophrenia. Br J Psychiatry (2004) 1.54
Geographic variation and sociodemographic characteristics of psychotic disorders in Finland. Schizophr Res (2008) 1.54
Self-inflicted burns: an eight year retrospective study in Finland. Burns (2004) 1.52
Reorganization of the primary somatosensory cortex during stroke recovery. Clin Neurophysiol (2010) 1.51
Seasonal changes, sleep length and circadian preference among twins with bipolar disorder. BMC Psychiatry (2003) 1.51
Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf (2011) 1.50
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry (2005) 1.48
Sex differences in cognition among persons with schizophrenia and healthy first-degree relatives. Psychiatry Res (2010) 1.46
Auditory discrimination after left-hemisphere stroke: a mismatch negativity follow-up study. Stroke (2003) 1.46
Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol (2012) 1.44
Diffusion-weighted MR imaging in normal human brains in various age groups. AJNR Am J Neuroradiol (2002) 1.43
Statins after ischemic stroke of undetermined etiology in young adults. Neurology (2011) 1.42
Level of suicidal intent predicts overall mortality and suicide after attempted suicide: a 12-year follow-up study. BMC Psychiatry (2004) 1.39
Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry (2004) 1.37
Determinants and outcomes of serious attempted suicide: a nationwide study in Finland, 1996-2003. Am J Epidemiol (2008) 1.35
Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry (2002) 1.35
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiol Dis (2002) 1.33
Genetic contributions to altered callosal morphology in schizophrenia. J Neurosci (2002) 1.33
Poststroke depression: an 18-month follow-up. Stroke (2003) 1.31
Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA (2004) 1.30
Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum Mol Genet (2007) 1.28
Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum Mol Genet (2006) 1.28
Burnout in the general population. Results from the Finnish Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol (2006) 1.27
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry (2011) 1.26
SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke (2012) 1.26
Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury. J Cereb Blood Flow Metab (2004) 1.23
Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke (2005) 1.22
No mental health without physical health. Lancet (2011) 1.22
Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med (2005) 1.21
Facilities available in European hospitals treating stroke patients. Stroke (2007) 1.18
Stroke thrombolysis: save a minute, save a day. Stroke (2014) 1.17
Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis (2005) 1.16
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J Circadian Rhythms (2009) 1.15
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry (2008) 1.13
Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. Am J Med Genet (2002) 1.13
High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol (2007) 1.12
Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke (2010) 1.11
Seasonal changes in mood and behavior are linked to metabolic syndrome. PLoS One (2008) 1.11
Employment status, mental disorders and service use in the working age population. Scand J Work Environ Health (2007) 1.10
Work stress, mental health and antidepressant medication findings from the Health 2000 Study. J Affect Disord (2006) 1.10
ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. PLoS One (2010) 1.09
Depression and C-reactive protein: population-based Health 2000 Study. Psychosom Med (2009) 1.08
Hazardous drinking: prevalence and associations in the Finnish general population. Alcohol Clin Exp Res (2008) 1.08
Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry (2010) 1.07